Management of Amniotic Fluid Embolism (AFE)

Management of AFE is largely supportive and hinges on prompt intervention to stabilize the patient’s airway, breathing, and circulation (the ABCs of resuscitation). Due to the rarity of AFE, many healthcare providers may not have extensive experience with its management, making the implementation of clinical checklists and protocols essential to guide care during this emergency.

The cornerstone of AFE management is effective cardiopulmonary resuscitation (CPR), which should be initiated immediately upon cardiovascular collapse. Chest compressions should be administered at a rate of 100 to 120 compressions per minute, with one ventilation every six seconds. Defibrillation may be necessary if a shockable rhythm is detected. In the case of cardiac arrest, rapid interventions are critical, including administering epinephrine every three to five minutes, securing intravenous or intraosseous access, and continuing resuscitative efforts.

If maternal cardiac arrest persists beyond four minutes, a perimortem cesarean section should be initiated to improve maternal hemodynamics and potentially save the fetus if viable. This procedure, often referred to as a resuscitative hysterotomy, should be performed at the bedside if necessary, as immediate fetal delivery can relieve pressure on the maternal vena cava and improve circulation.

Management of right ventricular failure is another critical component in AFE cases. Echocardiography can help guide the management of pulmonary hypertension and right ventricular dysfunction. Fluid administration should be carefully controlled to avoid exacerbating right ventricular overload, and inotropic support such as dobutamine or milrinone may be required to enhance cardiac function. Pulmonary vasodilators, such as epoprostenol or inhaled nitric oxide, can reduce pulmonary vascular resistance and improve right ventricular output.

Coagulopathy, which is a hallmark of AFE, must be managed aggressively. Patients often present with DIC, necessitating the administration of blood products in a 1:1:1 ratio of packed red blood cells (pRBCs), fresh frozen plasma (FFP), and platelets to correct clotting abnormalities. Tranexamic acid, an antifibrinolytic agent, should be administered early to prevent excessive bleeding. Cryoprecipitate may be preferred over FFP to reduce volume overload while replenishing critical clotting factors.

Extracorporeal membrane oxygenation (ECMO) may be considered for patients who do not respond to conventional resuscitative measures and develop refractory cardiogenic shock. ECMO can provide both respiratory and hemodynamic support, allowing the right ventricle time to recover while maintaining oxygenation and perfusion. Early identification of patients who may benefit from ECMO, along with timely transfer to a tertiary center with ECMO capabilities, can be life-saving in severe cases.

After fetal delivery, obstetric interventions focus on managing uterine atony and postpartum hemorrhage, which are common complications of AFE. Procedures such as uterine artery ligation, embolization, or compression sutures may be performed to control bleeding. In severe cases, an emergency hysterectomy may be required to stop life-threatening hemorrhage. Throughout the management of AFE, close collaboration among obstetricians, anesthesia providers, and critical care teams is essential to ensure comprehensive and effective care.

Post-event debriefing is critical for the healthcare team, providing an opportunity to review clinical decisions, outcomes, and areas for improvement. Participation in AFE registries and ongoing research into AFE treatment protocols will continue to improve management strategies and patient outcomes.